Our COPD evaluation approach

  • Delivery of NHS Guidelines for patients with COPD

    The delivery of high-quality care and associated healthcare outcomes, in any healthcare system, is entirely dependent upon the implementation of guidelines. There are effectively two aspects in relation to the delivery of evidenced based guidelines:

    The creation of the guidelines themselves

    The implementation of the guidelines

    LungHealth is focussing their support around the implementation (2) of the guidelines and that is the purpose of our Computer Guided Consultation (CGC) for COPD. LungHealth has created a product that assists specialist and non-specialist healthcare professionals to deliver a full and thorough guideline level review, for all patients with an existing diagnosis of COPD.

  • Assessing the effectiveness of the Computer Guided Consultation (CGC)

    “Does use of the CGC alter the clinical plan for the patient toward best care as defined by guidelines? To assess the effect of using the CGC we compared:

    Standard care before and after the LungHealth CGC versus the care being recommended following the LungHealth CGC

    This is not a study of health outcomes but of the processes of care being offered to patients. 

  • Elements of care during a COPD review

    Guidelines advice, based on best evidence, is that there are direct benefits from ensuring the following elements of care are incorporated into a COPD review:

    • An accurate diagnosis

    • An inhaler technique assessment to ensure that the patient can use their inhaler correctly

    • Correct drug treatment in line with the patient’s disease severity  

    • Ensure that the patient receives a written management (crisis) plan

    • Ensure that patients are referred for oxygen therapy (if appropriate) 

    • Ensure that patients are referred for pulmonary rehabilitation (if appropriate)

    • Referring continuing smokers to smoking cessation help

    The assessment of care at the start of the CGC explores whether the above actions have been documented in the patient’s historical record, and whether for example the spirometry traces are consistent with a diagnosis of COPD.

    During the CGC review, the clinician is prompted to consider each of the modifiable aspects of care. It remains up to the clinician and indeed the patient to decide whether to follow the prompt or not (note some patients will decline what is on offer and that is their right).  

    It is the analysis of the before and after changes in the patient clinical records that allows for our evaluation.

  • Statistical evaluations before and after the CGC

    Statistical evaluation shows that the changes made at a LungHealth consultation are highly statistically significant.

    We have performed a series of evaluations over the last few years comparing care before and after the CGC and presented these to our clinical colleagues in UK, Europe and the U.S. The summary of these presentations is included in our Resources section.

    We use the standard definitions of significance i.e. that a p value of <0.05 is significant but a value of <0.001 is highly significant i.e. most unlikely to be a chance observation.

The LungHealth Software has proved a beneficial tool, especially to our nursing staff who are not respiratory trained at present, alongside the guidance, patience and support of Kimberley it has facilitated an education opportunity in the review and monitoring of patients with COPD. The benefits of the in depth assessment of the patient's current condition and recommendations for appropriate treatment have been invaluable to us at this time.

— Rosina Reader, NHS - Lawson Road Surgery

Our COPD Clinical & Technical Risk Analysis

 

LungHealth guided consultation products, including COPD have been developed in an iterative manner from its conception of the idea, through to delivery of our current products. The final product has been developed by incorporating feedback from Respiratory Consultants, GPs, Practice Nurses, Commissioners of NHS Services, and any individual involved in delivering COPD care in today’s NHS. We have also had significant input from key opinion leader boards and indeed market research from patients to ensure that our guided consultation products meet with NHS as well as patient approval.

Contact us.

If you’re interested to learn more about our software solutions, get in touch with us.